These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39302104)

  • 1. Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis.
    Chougoni KK; Neely V; Ding B; Oduah E; Lam VT; Hu B; Koblinski JE; Windle BE; Palit Deb S; Deb S; Nieva JJ; Radhakrishnan SK; Harada H; Grossman SR
    Cancer Res Commun; 2024 Oct; 4(10):2685-2698. PubMed ID: 39302104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.
    Li C; Hu J; Li W; Song G; Shen J
    Biomater Sci; 2016 Dec; 5(1):77-88. PubMed ID: 27822577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
    Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Oncogenic Mutant p53 and BCL-2 for Small Cell Lung Cancer Treatment.
    Neely V; Manchikalapudi A; Nguyen K; Dalton K; Hu B; Koblinski JE; Faber AC; Deb S; Harada H
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma.
    Besse L; Kraus M; Besse A; Driessen C; Tarantino I
    Sci Rep; 2023 Mar; 13(1):4411. PubMed ID: 36932175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
    Lee I; Kalota A; Gewirtz AM; Shogen K
    Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Neuronal Stress with Activating Transcription Factor 3 in Dorsal Root Ganglion of in vivo and in vitro Models of Bortezomib- Induced Neuropathy.
    Yin Y; Qi X; Qiao Y; Liu H; Yan Z; Li H; Liu Z
    Curr Cancer Drug Targets; 2019; 19(1):50-64. PubMed ID: 30289077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy.
    Shen J; Song G; An M; Li X; Wu N; Ruan K; Hu J; Hu R
    Biomaterials; 2014 Jan; 35(1):316-26. PubMed ID: 24125776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression.
    Moriya S; Kazama H; Hino H; Takano N; Hiramoto M; Aizawa S; Miyazawa K
    PLoS One; 2023; 18(12):e0295273. PubMed ID: 38039297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells.
    Lan T; He S; Luo X; Pi Z; Lai W; Jiang C; Gan J; Wei S; Wu Z; Yun C; Leng J; Li C
    J Ethnopharmacol; 2024 Oct; 332():118340. PubMed ID: 38762212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG132 induced apoptosis is associated with p53-independent induction of pro-apoptotic Noxa and transcriptional activity of beta-catenin.
    Jüllig M; Zhang WV; Ferreira A; Stott NS
    Apoptosis; 2006 Apr; 11(4):627-41. PubMed ID: 16673057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daucosterol disturbs redox homeostasis and elicits oxidative-stress mediated apoptosis in A549 cells via targeting thioredoxin reductase by a p53 dependent mechanism.
    Rajavel T; Banu Priya G; Suryanarayanan V; Singh SK; Pandima Devi K
    Eur J Pharmacol; 2019 Jul; 855():112-123. PubMed ID: 31059712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells.
    Fink EE; Mannava S; Bagati A; Bianchi-Smiraglia A; Nair JR; Moparthy K; Lipchick BC; Drokov M; Utley A; Ross J; Mendeleeva LP; Savchenko VG; Lee KP; Nikiforov MA
    Leukemia; 2016 Jan; 30(1):104-11. PubMed ID: 26205085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
    Ong PS; Wang L; Chia DM; Seah JY; Kong LR; Thuya WL; Chinnathambi A; Lau JY; Wong AL; Yong WP; Yang D; Ho PC; Sethi G; Goh BC
    Cancer Lett; 2016 Oct; 381(1):49-57. PubMed ID: 27461583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer.
    Freire Boullosa L; Van Loenhout J; Flieswasser T; De Waele J; Hermans C; Lambrechts H; Cuypers B; Laukens K; Bartholomeus E; Siozopoulou V; De Vos WH; Peeters M; Smits ELJ; Deben C
    Redox Biol; 2021 Jun; 42():101949. PubMed ID: 33812801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.
    Ma L; Zhu Y; Fang S; Long H; Liu X; Liu Z
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28892004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.
    Ling YH; Liebes L; Jiang JD; Holland JF; Elliott PJ; Adams J; Muggia FM; Perez-Soler R
    Clin Cancer Res; 2003 Mar; 9(3):1145-54. PubMed ID: 12631620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib suppresses acute myelogenous leukaemia stem-like KG-1a cells via NF-κB inhibition and the induction of oxidative stress.
    Costa RGA; Oliveira MS; Rodrigues ACBDC; Silva SLR; Dias IRSB; Soares MBP; de Faro Valverde L; Gurgel Rocha CA; Dias RB; Bezerra DP
    J Cell Mol Med; 2024 Apr; 28(8):e18333. PubMed ID: 38652192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib exerts its anti-cancer activity through the regulation of Skp2/p53 axis in non-melanoma skin cancer cells and C. elegans.
    Prabhu KS; Ahmad F; Kuttikrishnan S; Leo R; Ali TA; Izadi M; Mateo JM; Alam M; Ahmad A; Al-Shabeeb Akil AS; Bhat AA; Buddenkotte J; Pourkarimi E; Steinhoff M; Uddin S
    Cell Death Discov; 2024 May; 10(1):225. PubMed ID: 38724504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.